The Effect of Soluble RAGE on Inhibition of Angiotensin II-Mediated Atherosclerosis in Apolipoprotein E Deficient Mice

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Lee, Dajeong ^a,c   Lee, Kyung Hye ^b   Park, Hyelim ^a,c   Kim, Soo Hyuk ^a,c   Jin, Taewon ^a,c   Cho, Soyoung ^c   Chung, Ji Hyung ^a,c   Lim, Soyeon ^c   Park, Sungha ^a,c  

^a Yonsei University   (South Korea)

^b Kyung Hee University College of Medicine   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; ANGIOTENSIN II; CYTOKINE; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; VASCULAR CELL ADHESION MOLECULE 1;

ABDOMINAL AORTA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA MEDIA; ARTICLE; ASCENDING AORTA; ATHEROSCLEROTIC PLAQUE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; GENE EXPRESSION; ICAM 1 GENE; INHIBITION KINETICS; MALE; MCP 1 GENE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RAGE GENE; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; ANIMALS; AORTA; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD PRESSURE; CELL ADHESION MOLECULES; GENE EXPRESSION REGULATION; GENE KNOCKOUT TECHNIQUES; HUMANS; INFLAMMATION; MALE; MICE; MUSCLE, SMOOTH, VASCULAR; PLAQUE, ATHEROSCLEROTIC; RATS; RECEPTORS, IMMUNOLOGIC; SOLUBILITY;

EID: 84880980969     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069669     Document Type: Article

References (33)

1. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, et al. (2000) Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342: 145-153.
2. Mehta PK, Griendling KK, (2007) Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 292: C82-97.
3. Schmidt AM, Vianna M, Gerlach M, Brett J, Ryan J, et al. (1992) Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J Biol Chem 267: 14987-14997.
4. Neeper M, Schmidt AM, Brett J, Yan SD, Wang F, et al. (1992) Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 267: 14998-15004.
5. Chavakis T, Bierhaus A, Al-Fakhri N, Schneider D, Witte S, et al. (2003) The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J Exp Med 198: 1507-1515.
6. Vazzana N, Santilli F, Cuccurullo C, Davi G, (2009) Soluble forms of RAGE in internal medicine. Intern Emerg Med 4: 389-401.
7. Bierhaus A, Humpert PM, Morcos M, Wendt T, Chavakis T, et al. (2005) Understanding RAGE, the receptor for advanced glycation end products. J Mol Med (Berl) 83: 876-886.
8. Alexiou P, Chatzopoulou M, Pegklidou K, Demopoulos VJ, (2010) RAGE: a multi-ligand receptor unveiling novel insights in health and disease. Curr Med Chem 17: 2232-2252.
9. Weiss D, Kools JJ, Taylor WR, (2001) Angiotensin II-induced hypertension accelerates the development of atherosclerosis in Apo E-deficient mice. Circulation 103: 448-454.
10. Lin L, Park S, Lakatta EG, (2009) RAGE signaling in inflammation and arterial aging. Front Biosci 14: 1403-1413.
11. Saraff K, Babamusta F, Cassis LA, Daugherty A, (2003) Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 23: 1621-1626.
12. Lee HW, Na YJ, Jung PK, Kim MN, Kim SM, et al. (2008) Nerve growth factor stimulates proliferation, adhesion and thymopoietic cytokine expression in mouse thymic epithelial cells in vitro. Regul Pept 147: 72-81.
13. Choi JW, Lee KH, Kim SH, Jin T, Lee BS, et al. (2011) C-reactive protein induces p53-mediated cell cycle arrest in H9c2 cardiac myocytes. Biochem Biophys Res Commun 410: 525-530.
14. Chen CY, Abell AM, Moon YS, Kim KH, (2012) An advanced glycation end product (age)-receptor for ages (rage) axis restores adipogenic potential of senescent preadipocytes through modulation of p53 protein function. J Biol Chem 287: 44498-44507.
15. Ling HP, Li W, Zhou ML, Tang Y, Chen ZR, et al. (2013) Expression of intestinal myeloid differentiation primary response protein 88 (myd88) following experimental traumatic brain injury in a mouse model. J Surg Res 179: e227-234.
16. Radeke HH, Janssen-Graalfs I, Sowa EN, Chouchakova N, Skokowa J, et al. (2002) Opposite regulation of type II and III receptors for immunoglobulin G in mouse glomerular mesangial cells and in the induction of anti-glomerular basement membrane (GBM) nephritis. J Biol Chem 277: 27535-27544.
17. Patole PS, Schubert S, Hildinger K, Khandoga S, Khandoga A, et al. (2005) Toll-like receptor-4: renal cells and bone marrow cells signal for neutrophil recruitment during pyelonephritis. Kidney Int 68: 2582-2587.
18. Brewster UC, Setaro JF, Perazella MA, (2003) The renin-angiotensin-aldosterone system: cardiorenal effects and implications for renal and cardiovascular disease states. Am J Med Sci 326: 15-24.
19. Dzau V (2005) The cardiovascular continuum and renin-angiotensin-aldosterone system blockade. J Hypertens Suppl 23: S9-17.
20. Cheng ZJ, Vapaatalo H, Mervaala E, (2005) Angiotensin II and vascular inflammation. Med Sci Monit 11: RA194-205.
21. Pueyo ME, Gonzalez W, Nicoletti A, Savoie F, Arnal JF, et al. (2000) Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress. Arterioscler Thromb Vasc Biol 20: 645-651.
22. Weaver M, Liu J, Pimentel D, Reddy DJ, Harding P, et al. (2006) Adventitial delivery of dominant-negative p67phox attenuates neointimal hyperplasia of the rat carotid artery. Am J Physiol Heart Circ Physiol 290: H1933-1941.
23. Dourron HM, Jacobson GM, Park JL, Liu J, Reddy DJ, et al. (2005) Perivascular gene transfer of NADPH oxidase inhibitor suppresses angioplasty-induced neointimal proliferation of rat carotid artery. Am J Physiol Heart Circ Physiol 288: H946-953.
24. Jandeleit-Dahm K, Watson A, Soro-Paavonen A, (2008) The AGE/RAGE axis in diabetes-accelerated atherosclerosis. Clin Exp Pharmacol Physiol 35: 329-334.
25. Bierhaus A, Stern DM, Nawroth PP, (2006) RAGE in inflammation: a new therapeutic target? Curr Opin Investig Drugs 7: 985-991.
26. Ihara Y, Egashira K, Nakano K, Ohtani K, Kubo M, et al. (2007) Upregulation of the ligand-RAGE pathway via the angiotensin II type I receptor is essential in the pathogenesis of diabetic atherosclerosis. J Mol Cell Cardiol 43: 455-464.
27. Wooley PH, Dutcher J, Widmer MB, Gillis S, (1993) Influence of a recombinant human soluble tumor necrosis factor receptor FC fusion protein on type II collagen-induced arthritis in mice. J Immunol 151: 6602-6607.
28. Bucciarelli LG, Wendt T, Qu W, Lu Y, Lalla E, et al. (2002) RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice. Circulation 106: 2827-2835.
29. Lee SW, Park KH, Park S, Kim JH, Hong SY, et al. (2013) Soluble receptor for advanced glycation end products alleviates nephritis in NZB/WF1 mice. Arthritis Rheum.
30. Rai V, Maldonado AY, Burz DS, Reverdatto S, Yan SF, et al. (2012) Signal transduction in receptor for advanced glycation end products (RAGE): solution structure of C-terminal rage (ctRAGE) and its binding to mDia1. J Biol Chem 287: 5133-5144.
31. Chae CU, Lee RT, Rifai N, Ridker PM, (2001) Blood pressure and inflammation in apparently healthy men. Hypertension 38: 399-403.
32. Yu M, Wang H, Ding A, Golenbock DT, Latz E, et al. (2006) HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock 26: 174-179.
33. Liliensiek B, Weigand MA, Bierhaus A, Nicklas W, Kasper M, et al. (2004) Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J Clin Invest 113: 1641-1650.